4//SEC Filing
CORAUTUS GENETICS INC 4
Accession 0001181431-07-038641
CIK 0001003929operating
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:07 PM ET
Size
9.6 KB
Accession
0001181431-07-038641
Insider Transaction Report
Form 4
LARSON JOHN RANDOLPH
Director
Transactions
- Award
Stock Option (right to buy)
2007-06-05+5,575→ 20,957 totalExercise: $5.10From: 2007-06-05Exp: 2017-06-05→ Common Stock (5,575 underlying)
Footnotes (1)
- [F1]Reflects a 1-for-15 reverse stock split, which became effective on June 5, 2007. In connection with the merger of VIA Pharmaceuticals, Inc. with Corautus Genetics Inc. (the "Merger"), the 15,382 (on a reverse split adjusted basis) stock options held by Mr. Larson prior to the consummation of the Merger became immediately exercisable, and as a result, all 20,957 stock options held by Mr. Larson are exercisable.
Issuer
CORAUTUS GENETICS INC
CIK 0001003929
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001003929
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 5:07 PM ET
- Size
- 9.6 KB